Page last updated: 2024-11-04

sulfasalazine and Central Nervous System Diseases

sulfasalazine has been researched along with Central Nervous System Diseases in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donovan, S1
Hawley, S1
MacCarthy, J1
Scott, DL1

Trials

1 trial available for sulfasalazine and Central Nervous System Diseases

ArticleYear
Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
    British journal of rheumatology, 1990, Volume: 29, Issue:3

    Topics: Arthritis, Rheumatoid; Central Nervous System Diseases; Drug Eruptions; Female; Gastrointestinal Dis

1990

Other Studies

1 other study available for sulfasalazine and Central Nervous System Diseases

ArticleYear
Drugs for rheumatoid arthritis.
    The Medical letter on drugs and therapeutics, 2000, Jul-10, Volume: 42, Issue:1082

    Topics: Administration, Oral; Adrenal Cortex Hormones; Anorexia; Anti-Inflammatory Agents, Non-Steroidal; An

2000